References
Vindelov L. Allogeneic bone marrow transplantation with reduced conditioning.Eur J Haematol. 2001;66:73–82.
Gómez-Almaguer D, Ruiz-ArgüellesGJ, Ruiz-Argüelles A, González-Llano O, Cantú OG, Hernández NE. Hematopoietic stem cell allografts using a non-myeloablative conditioning regimen can be safely performed on an outpatient basis.Bone Marrow Transpl. 2000:131–133.
Ruiz-Argüelles GJ, Gómez-Almaguer D, Ruiz-Argüelles A, González-Llano O, Cantú OG, Jaime-Pérez JC. Results of an outpatient-based stem cell allotransplant program using nonmyeloablative conditioning regimens.Am J Hematol. 2001;66: 241–244.
Ruiz-Argüelles GJ. Outpatient programs of myeloablative chemotherapy, autologous and allogeneic bone marrow transplantation.Haematologica. 2000;85:1233–1234.
Ruiz-Argüelles GJ. “The Mexican approach” to conduct nonmyeloablative stem cell transplantation.Eur J Haematol. 2001;67: 5–6.
Ruiz-Argüelles GJ, Gómez-Almaguer D, López-Martínez B, Ponce-de-Leün S, Cantú-Rodríguez OG, Jaime-Pérez JC. No cytomegalovirus-related deaths after non-ablative stem cell allografts.Hematology. 2002;7:95–99.
Ruiz-Argüelles GJ, López-Martínez B, Santellán-Olea MR, et al. Follow up of hemopoietic chimerism in individuals given allogeneic hemopoietic stem cell allografts using an immunosuppressive, non-myeloablative conditioning regimen: A prospective study in a single institution.Leukemia Lymph. 2002;43:1509–1511.
Ruiz-Argüelles GJ, Gómez-Almaguer D, López-Martínez B, Cantú-Rodríguez OG, Jaime-Pérez JC, González-Llano O. Results of an allogeneic non-myeloablative stem cell transplantation program in patients with chronic myelogenous leukemia.Haematologica. 2002;87:894–896.
Ruiz-Argüelles GJ. The graft versus leukemia effect in chronic myelogenous leukemia.Rev Invest Clín Mex. 2002;54:154–160.
Ruiz-Argüelles GJ. Allogeneic stem cell transplantation using non-myeloablative conditioning regimens: results of the Mexican approach.Int J Hematol. 2002;76(suppl 1):376–379.
Gómez-Almaguer D, Ruiz-Argüelles GJ, Tarín-Arzaga LC, et al. Reduced-intensity stem cell transplantation in children and adolescents: the Mexican experience.Biol Blood Marrow Transpl. 2003;9:157–161.
Ruiz-Argüelles GJ, López-Martínez B, Gómez-Rangel D, et al. Decreased transfusion requirements in patients given stem cell allografts using a non-myeloablative conditioning regimen: a single institution experience.Hematology. 2003; in press.
Giralt S, Estey E, Albitar M, et al. Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeoablative therapy.Blood. 1997;89:4531–4536.
Slavin S, Nagler A, Naparstek E, et al. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematological diseases.Blood. 1998;91:756–763.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Ruiz-Argüelles, G.J., Gómez-Almaguer, D. The Mexican Approach to Conduct Nonmyeloablative Stem Cell Transplantation Should Not Be Overlooked. Int J Hematol 77, 526–527 (2003). https://doi.org/10.1007/BF02986624
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF02986624